Empagliflozin PBS expansion will cover all HF patients
The listing will cover all patients with symptomatic heart failure across the ejection fraction spectrum.
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/senior-patient-man-chest-heart-iStock-1299148057.jpg)
The PBS listing for empagliflozin will soon be expanded to cover all patients with symptomatic heart failure regardless of ejection fraction.
From 1 November, doctors can issue PBS scripts for 10mg daily empagliflozin (Jardiance) for heart failure with left ventricular ejection fraction (LVEF) greater than 40% as an adjunct to standard therapy.